| abstract |
The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I): n n n n n n n n n n wherein R 1 represents a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R 2 and R 3 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R 4 and R 5 are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R 6 represents a hydrogen atom or the like, each R 7 may be the same or different and may each represent an optionally substituted C1-6 alkoxy group or the like, X represents —CH═, —C(—R 7 )═, or —N═, and m represents 1 to 4, or a pharmacologically acceptable salt thereof. |